NasdaqGS - Nasdaq Real Time Price USD

Twist Bioscience Corporation (TWST)

40.17

+2.55

+(6.78%)

At close: April 24 at 4:00:01 PM EDT

39.51

-0.66

(-1.64%)

Pre-Market: 4:24:33 AM EDT

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

SOUTH SAN FRANCISCO, Calif., April 24, 2025--Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

Business Wire 21 hours ago

TWST
+6.78%
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025

SOUTH SAN FRANCISCO, Calif., April 14, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 second quarter ended March 31, 2025, before the opening of the market on May 5, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial

Business Wire 10 days ago

TWST
+6.78%
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics are part of the Zacks top Analyst Blog

Zacks 24 days ago

CRSP
+1.48%
WVE

TWST
+6.78%
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich., March 31, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics software, today announced a collaboration to accelerate the adoption of NGS workflows in agricultural genomics (agrigenomics) by offering Twist’s FlexPrep™ Ultra-High Throughput (UHT) Library Preparation Kit with Curio’s bioinformatics software a

Business Wire 24 days ago

TWST
+6.78%
Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against other worst high-risk high-reward growth stocks to buy. Is the Tariff Solution Around the Corner? On March 14, Tom Lee managing partner and […]

Insider Monkey last month

TWST
+6.78%
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?

Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks last month

TWST
+6.78%
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

SOUTH SAN FRANCISCO, Calif., March 11, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time, all Twist Express Genes orders placed by academic customers globally will be shipped in as few as four days* without incurring a premium for the rapid turnaround time.

Business Wire last month

TWST
+6.78%
Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now?

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against other best immunology stocks to buy now. The Growing Market for Immune System Treatments Immunology is a rapidly advancing field with significant potential for […]

Insider Monkey last month

TWST
+6.78%
Twist Bioscience to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., February 25, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:

Business Wire last month

TWST
+6.78%
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., February 19, 2025--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it has granted a total of 123,024 equity awards, consisting of 72,394 restricted stock units ("RSUs") and up to 50,630 performance stock units ("PSUs"), to 32 recently hired individuals, in each case as

Business Wire 2 months ago

TWST
+6.78%
Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Twist Bioscience Corporation ( NASDAQ:TWST ) investors will be delighted, with the company turning in some strong...

Simply Wall St. 2 months ago

TWST
+6.78%
Twist Bioscience Corporation (TWST): Among Cathie Wood’s Top Stock Picks for 2025

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s most contentious figures. She founded ARK Investment Management around ten […]

Insider Monkey 2 months ago

TWST
+6.78%
Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know

Twist Bioscience (TWST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks 2 months ago

TWST
+6.78%
BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin Up

BDX's overall topline in the first quarter of fiscal 2025 continues to benefit from revenue growth in all segments.

Zacks 2 months ago

BDX

RMD

TWST
+6.78%
Company News for Feb 4, 2025

Companies In The News Are: ARLP, TSN, IDXX, TWST.

Zacks 2 months ago

TWST
+6.78%
TSN
Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Twist Bioscience Corp (TWST) reports a 24% revenue increase and improved gross margins, while outlining strategic plans for future growth and profitability.

GuruFocus.com 2 months ago

TWST
+6.78%
Q1 2025 Twist Bioscience Corp Earnings Call

Q1 2025 Twist Bioscience Corp Earnings Call

Thomson Reuters StreetEvents 2 months ago

TWST
+6.78%
Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) delivered earnings and revenue surprises of 14.52% and 2.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

TWST
+6.78%
Twist Bioscience: Fiscal Q1 Earnings Snapshot

The South San Francisco, California-based company said it had a loss of 53 cents per share. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.

Associated Press Finance 2 months ago

TWST
+6.78%
Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

SOUTH SAN FRANCISCO, Calif., February 03, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the first quarter fiscal 2025 ended December 31, 2024.

Business Wire 2 months ago

TWST
+6.78%

Performance Overview

Return	TWST	S&P 500 (^GSPC)
YTD	-13.56%	-6.75%
1-Year	+30.63%	+8.15%
3-Year	+17.42%	+28.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Twist Bioscience Corporation (TWST)

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy

Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now?

Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Twist Bioscience Corporation (TWST): Among Cathie Wood’s Top Stock Picks for 2025

Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know

BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin Up

Company News for Feb 4, 2025

Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Q1 2025 Twist Bioscience Corp Earnings Call

Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates

Twist Bioscience: Fiscal Q1 Earnings Snapshot

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

Performance Overview